Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies today with an urgent need for novel therapeutic strategies. Biomarker analysis helps to better understand tumor biology and might emerge as a tool to develop personalized therapies. The aim of the study is to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Popp, Felix C., Popp, Marie Christine, Zhao, Yue, Betzler, Christopher, Kropf, Siegfried, Garlipp, Benjamin, Benckert, Christoph, Kalinski, Thomas, Lippert, Hans, Bruns, Christiane J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371262/
https://ncbi.nlm.nih.gov/pubmed/28356064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3186-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados